| [1] |
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. |
| [2] |
Zheng R, Sun K, Han B, Li L, Chen R, et al. 2026. Cancer incidence and mortality in China, 2024. |
| [3] |
Xia C, Li H, Wu C, Chen W. 2026. Cancer burden and control in China: landscape, trends and challenges. |
| [4] |
Zeng H, Zheng R, Sun K, Zhou M, Wang S, et al. 2024. Cancer survival statistics in China 2019–2021: a multicenter, population-based study. |
| [5] |
Liu X, Li X, Yang F. 2022. Pattern of recurrence and metastasis after radical resection of non-small cell lung cancer. |
| [6] |
Zeng H, Ran X, An L, Zheng R, Zhang S, et al. 2021. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. |
| [7] |
Reuss JE, Bazhenova L, Ismaila N, Abu Rous F, Ahluwalia A, et al. 2026. Therapy for stage IV non-small cell lung cancer without driver alterations: ASCO living guideline, 2026.3.0. |
| [8] |
Verberkt CA, Billingy NE, Becker-Commissaris A, van den Hurk CJG, de Heij AH, et al. 2026. Distinct trajectories of symptom burden development in patients with stage IV cancer. |
| [9] |
Pasello G, Lorenzi M, Scattolin D, Del Conte A, Cecere F, et al. 2024. Osimertinib in patients with treatment-naive EGFR-mutant non-small cell lung cancer: overall survival, post-progression management and budget impact analysis in real-world. |
| [10] |
Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, et al. 2024. Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. |
| [11] |
Li Y, Wang Q, Liu C, Hu X. 2023. Symptom clusters and their impact on quality of life among Chinese patients with lung cancer: a cross-sectional study. |
| [12] |
Takemura N, Cheung DST, Fong DYT, Ho MH, Lin CC. 2023. Relationship between cortisol rhythm and psychoneurological symptom cluster in patients with advanced lung cancer. |
| [13] |
Ju X, Bai J, She Y, Zheng R, Xu X, et al. 2023. Symptom cluster trajectories and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer. |
| [14] |
Li N, Wu J, Zhou J, Wu C, Dong L, et al. 2021. Symptom clusters change over time in patients with lung cancer during perichemotherapy. |
| [15] |
Wong ML, Cooper BA, Paul SM, Levine JD, Conley YP, et al. 2017. Differences in symptom clusters identified using ratings of symptom occurrence vs severity in lung cancer patients receiving chemotherapy. |
| [16] |
Dodd MJ, Miaskowski C, Paul SM. 2001. Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum 28:465−470 |
| [17] |
Miaskowski C, Dodd M, Lee K. 2004. Symptom clusters: the new frontier in symptom management research. |
| [18] |
Kim HJ, McGuire DB, Tulman L, Barsevick AM. 2005. Symptom clusters: concept analysis and clinical implications for cancer nursing. |
| [19] |
Choi YY, Akter J, Lee J. 2024. Symptom clusters among lung cancer patients: a scoping review. |
| [20] |
Shao X, Wang N, Tang K, Wang K, Tan Z, et al. 2025. Network analysis used to investigate the symptoms of cancer patients during chemotherapy: a scoping review. |
| [21] |
Li Y, Hu X. 2025. Symptom clusters and core symptoms of Chinese patients with lung cancer: a cross-sectional study. |
| [22] |
Bulto LN, Davies E, Kelly J, Hendriks JM. 2024. Patient journey mapping: emerging methods for understanding and improving patient experiences of health systems and services. |
| [23] |
Tong A, Sainsbury P, Craig J. 2007. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. |
| [24] |
LaDonna KA, Artino AR Jr, Balmer DF. 2021. Beyond the guise of saturation: rigor and qualitative interview data. |
| [25] |
Colaizzi PF. 1978. Psychological research as the phenomenologist views it. In Existential-Phenomenological Alternatives for Psychology, eds. Valle RS, King M. New York: Oxford University Press. pp. 48−71 https://ci.nii.ac.jp/naid/10028127253 |
| [26] |
Zhang F, Wang Y, Xiao Y, Li J, Liu Y, et al. 2026. Journey mapping of the patient experience from diagnosis to end of life in lung cancer: a qualitative meta-synthesis. |
| [27] |
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, et al. 2001. Advancing the science of symptom management. |
| [28] |
Jia R, Zou J, Hu H, Wang X, Zheng Y, et al. 2025. Patient-reported outcomes with first-line immunotherapy-based combination treatment for advanced lung cancer: a prospective, multicenter, observational study. |
| [29] |
Petrasso C, Bayly J, Fettes L, Ashford S, Maddocks M. 2025. Interplay between mobility, social participation, and symptom burden in advanced lung cancer. |
| [30] |
Liu T, He J, Wang Y, Yang Y, Zhang L, et al. 2025. Health-related quality of life and symptoms in patients with previously untreated, locally advanced or metastatic non-squamous non-small cell lung cancer treated with sintilimab or placebo plus pemetrexed and platinum (ORIENT-11): a randomized, double-blind, phase 3 trial. |
| [31] |
Yan Z, Xiao LD, Guo X, Hu Y, Wang N, et al. 2025. The impact of social support and social constraints on sleep disturbances in patients with lung cancer undergoing chemotherapy: serial mediators of sleep cognition and anxiety-depression. |
| [32] |
Zhou Z, Yang Y, Sun J, Dong Y, Zhu M, et al. 2024. Heterogeneity of pain-fatigue-sleep disturbance symptom clusters in lung cancer patients after chemotherapy: a latent profile analysis. |
| [33] |
Crawford J, Herndon D, Gmitter K, Weiss J. 2024. The impact of myelosuppression on quality of life of patients treated with chemotherapy. |
| [34] |
Duan L, Cui H, Zhang W, Wu S. 2022. Symptoms and experiences of frailty in lung cancer patients with chemotherapy: a mixed-method approach. |
| [35] |
Mao D, Luo Y, Zhang L, Liu S, Zhu B, et al. 2025. Trajectories of fatigue-pain-sleep disturbance symptom cluster in patients with lung cancer undergoing chemotherapy and its predictive factors: latent class growth model. |
| [36] |
Defty J, Wagland R, Turnbull J, Richardson A. 2025. Symptom appraisal and help-seeking for complications of cancer and its treatment: a systematic review and qualitative synthesis. |
| [37] |
Cassim S, Chepulis L, Keenan R, Kidd J, Firth M, et al. 2019. Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review. |
| [38] |
Zhang J, IJzerman MJ, Oberoi J, Karnchanachari N, Bergin RJ, et al. 2022. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. |
| [39] |
Rowntree RA, Hosseinzadeh H. 2022. Lung cancer and self-management interventions: a systematic review of randomised controlled trials. |